Inhibition of Nicotinamide adenine dinucleotide phosphate oxidase 4 attenuates cell apoptosis and oxidative stress in a rat model of polycystic ovary syndrome through the activation of Nrf-2/HO-1 signaling pathway

Mol Cell Endocrinol. 2022 Jun 15:550:111645. doi: 10.1016/j.mce.2022.111645. Epub 2022 Apr 9.

Abstract

Polycystic ovary syndrome (PCOS) is a common reproductive endocrine disorder in reproductive-aged women. In this study, a rat model of PCOS was established by subcutaneous injection of dehydroepiandrosterone (DHEA). NOX4 was highly expressed in PCOS rat ovaries, while its specific role in PCOS remains unclear. Lentivirus-mediated shRNA targeting NOX4 inhibited oxidative stress by reducing ROS, 4-HNE and MDA levels, and increasing SOD and GPX activities in rat ovaries. NOX4 deficiency increased Bcl-2 levels and decreased Bax, cleaved caspase-3 and cleaved caspase-9 levels and DHEA-induced cell apoptosis in rat ovaries. Similar to the in vivo results, NOX4 silencing inhibited oxidative stress and cell apoptosis in DHEA-treated rat granulosa cells. Moreover, NOX4 silencing promoted Nrf-2 translocation, and the expression of Nrf-2 and HO-1 both in vivo and in vitro. Thus, NOX4 deficiency may ameliorate PCOS in rats by reducing oxidative stress and cell apoptosis via activating the Nrf-2/HO-1 signal pathway.

Keywords: Apoptosis; Granulosa cells; NOX4; Nrf-2; Oxidative stress; PCOS.

MeSH terms

  • Adult
  • Animals
  • Apoptosis
  • Dehydroepiandrosterone / adverse effects
  • Female
  • Humans
  • NADP / metabolism
  • NADPH Oxidase 4 / genetics
  • NADPH Oxidase 4 / metabolism
  • Oxidative Stress
  • Polycystic Ovary Syndrome* / metabolism
  • Rats
  • Signal Transduction / genetics

Substances

  • Dehydroepiandrosterone
  • NADP
  • NADPH Oxidase 4